GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared ...
Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration subcutaneous co-formulation consisting of HER2 ...
Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...
The P hase II study for diabetes is a 13-week, randomized, double-blind, placebo-controlled and multi-center study to evaluate the efficacy, safety, and tolerability of ASC30 ...
A few 2025 trials pointed in the same direction: toward treatments built to modify disease biology and better ways to measure ...
Switzerland: A randomized trial has found that adding a daily fish oil supplement to psychotherapy did not provide any ...
Highlighting the need for stronger post-marketing safety oversight, the Subject Expert Committee (SEC) of the Central Drugs ...
This scoping review identifies the first wave of randomized controlled trials testing large language models in digestive diseases. Four published and ten ongoing trials suggest that AI tools such as ...
In this exclusive MedPage Today video, Specht is joined via Zoom by study co-lead, Heather Jacene, MD, of Brigham and Women's ...
News-Medical.Net on MSN
Trial evaluates a traditional Chinese herbal formula for diabetic kidney disease with macroalbuminuria
Diabetic kidney disease affects a growing proportion of people with diabetes and remains the leading cause of end-stage renal ...
In this MedPage Today video, Taylor Brooks, MD, of the Cleveland Clinic Cancer Institute, discusses real-world survival ...
A large U.S. randomized trial published in the New England Journal of Medicine found that etomidate, compared with ketamine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback